Adenosine 3',5'-cyclic monophosphate sodium salt
Synonym(s):3′,5′-Cyclic AMP sodium salt;cAMP-Na
- CAS NO.：37839-81-9
- Empirical Formula: C10H13N5NaO6P
- Molecular Weight: 353.21
- MDL number: MFCD00069736
- EINECS: 253-328-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-01-13 11:13:14
What is Adenosine 3',5'-cyclic monophosphate sodium salt?
Chemical properties
White crystalline powder
The Uses of Adenosine 3',5'-cyclic monophosphate sodium salt
Adenosine 3',5'-cyclic monophosphate sodium salt is an Adenosine (A280400) derivative useful as anticancer agent.
The Uses of Adenosine 3',5'-cyclic monophosphate sodium salt
Adenosine 3?,5?-cyclic monophosphate sodium salt monohydrate is used as an activator of protein kinase A (PKA) . A key regulator of many cellular reactions. Released in response to hormonal stimulation. . Directly activates Epac, a Rap1 guanine-nucleotide exchange factor. Acts as a second messenger in signal transduction mechanisms. Promotes apoptosis in resting human B lymphocytes.
What are the applications of Application
Adenosine 3′,5′-cyclic monophosphate sodium salt monohydrate is a PKA (protein kinase A) activator
Biochem/physiol Actions
Naturally-occurring activator of cyclic-AMP-dependent protein kinase (PKA). cAMP is an important second messenger that is linked in many systems to neurotransmitter- or hormone-induced receptor stimulation. The cAMP/PKA signaling pathway has been shown to inhibit cell proliferation, induce differentiation and lead to apoptosis.
Properties of Adenosine 3',5'-cyclic monophosphate sodium salt
| storage temp. | -20°C |
| solubility | H2O: 50 mg/mL |
| form | powder |
| color | white |
| Water Solubility | Soluble in water (50 mg/ml). |
| BRN | 54612 |
| Stability: | Hygroscopic |
| CAS DataBase Reference | 37839-81-9 |
Safety information for Adenosine 3',5'-cyclic monophosphate sodium salt
| Signal word | Warning |
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for Adenosine 3',5'-cyclic monophosphate sodium salt
New Products
2-(3-Methyl-1,2,4-oxadiazol-5-yl)acetic acid (as potassium salt) 2-fluoro-4-iodoaniline 4-Iodo-3,5-dimethylbenzonitrile Atorvastatin amide impurity/Atorvastatin EP Impurity F(Calcium Salt) Lantanoprost rc B Clidinium Bromide Impurity Noradrenaline EP Impurity D/Noradrenaline Methyl Ether Cetirizine EP Impurity A/Cetirizine CBHP Impurity N-Nitroso hydroxy Cetrizine EP Impurity-A (4-Fluoro-2-methoxy-5-nitro- phenyl)-[4- (1-methyl-1H- indol-3- yl)-pyrimidin-2-yl]- amine 6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole tert-butyl 4-(6-((7-cyclo pentyl -6-(dimethyl carbamoyl) -7H-pyrrolo [2,3-d]pyrimidin-2-yl) amino)pyridin-3-yl) piperazine-1-carboxylate 2-Fluoro-4-nitrotoluene 1-(2-amino-5-hydroxy phenyl)propan-1-one (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3- amine 3-(Dimethylamino)benzoic acid 2-Amino-5-chloropyridine 4-(Methylamino)-3-nitrobenzoic Acid 5-Chloro-2-Nitroaniline 3,5-dibenzyloxy Acetophenone 2,4-Diamino-6-hydroxypyrimidine 2-Chloro Benzylcyanide 3-chlorobenzyl cyanide 3,4 Diethoxy BenzylcyanideRelated products of tetrahydrofuran
You may like
-
Adenosine 3',5'-Cyclic Monophosphate Sodium Salt CAS 37839-81-9View Details
37839-81-9 -
Adenosine 3′,5′-cyclic monophosphate sodium salt, monohydrate, ≥98% (HPLC) CAS 37839-81-9View Details
37839-81-9 -
c-AMP sodium salt 98% CAS 37839-81-9View Details
37839-81-9 -
Adenosine 3′,5′-cyclic monophosphate sodium salt monohydrate CAS 37839-81-9View Details
37839-81-9 -
1122-58-3 99%View Details
1122-58-3 -
2-Chlorotrityl Chloride 99%View Details
42074-68-0 -
5-Bromo-2-chlorobenzoic acid 21739-92-4 99%View Details
21739-92-4 -
106-40-1 99%View Details
106-40-1